Aldose reductase and the polyol pathway in Schwann cells: old and new problems
Individuals with prior use of oral antidiabetic drugs or GLP-1 receptor agonists, a history of bariatric surgery, or conditions associated with unintentional weight loss (including malignancy or chronic infection) were excluded
The breakdown illustrates why evidence-based practitioners default to retinoids as the clinical standard while remaining appropriately open to GHK-Cu as a complementary option
Skalny AV, Tinkov AA, Voronina I, et al
Body composition gets tracked too, on an InBody 770 scan at every visit, because weight loss that's half muscle is a bad trade
Boucher J, Tseng YH, Kahn CR